Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Afatinib maintenance after radio-chemotherapy in head and neck squamous cell carcinoma
NCT01427478Phase 3Completed
- Sponsor
- Centre Léon Bérard
- Start
- Sep 2011
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of afatinib in head and neck squamous cell carcinoma (HNSCC), sponsored by Centre Léon Bérard. Started Sep 2011; status: completed.
02
Drugs
afatinib
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT01427478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01427478.